<table class=wikitable><tr><th>Name</th><th>Investigation</th><th>Route of administration</th><th>In-vitro / in-vivo</th><th>Imaging / non-imaging</th></tr><tr><td>In111-DTPA ( diethylenetriaminepenta-acetic acid )</td><td>Ventriculo-peritoneal shunt (LaVeen Shunt)</td><td>intraperitoneal injection</td><td>In-vivo</td><td>Imaging</td></tr><tr><td>In111-DTPA ( diethylenetriaminepenta-acetic acid )</td><td>Cisternography</td><td>Intra-cisternal</td><td>In-vivo</td><td>Imaging</td></tr><tr><td>In111- s Leukocyte</td><td>Infection/inflammation imaging</td><td>IV</td><td>In-vivo</td><td>Imaging</td></tr><tr><td>In111- s Platelet</td><td>Thrombus imaging</td><td>IV</td><td>In-vivo</td><td>Imaging</td></tr><tr><td>In111-Pentetreotide</td><td>Somatostatin receptor imaging</td><td>IV</td><td>In-vivo</td><td>Imaging</td></tr><tr><td>In111-Octreotide</td><td>Somatostatin receptor imaging ( Octreoscan )</td><td>IV</td><td>In-vivo</td><td>Imaging</td></tr></table>
